We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA: Update Risk Management Plans After Manufacturing Change
EMA: Update Risk Management Plans After Manufacturing Change
The European Medicines Agency is recommending that drugmakers update their risk management plans when switching to a new manufacturing process for products with centralized marketing authorization.